JP6875297B2 - 骨形成性移植片形成ユニット - Google Patents
骨形成性移植片形成ユニット Download PDFInfo
- Publication number
- JP6875297B2 JP6875297B2 JP2017564535A JP2017564535A JP6875297B2 JP 6875297 B2 JP6875297 B2 JP 6875297B2 JP 2017564535 A JP2017564535 A JP 2017564535A JP 2017564535 A JP2017564535 A JP 2017564535A JP 6875297 B2 JP6875297 B2 JP 6875297B2
- Authority
- JP
- Japan
- Prior art keywords
- bone
- cells
- progenitor cells
- cell
- forming
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000015572 biosynthetic process Effects 0.000 title claims description 7
- 210000004027 cell Anatomy 0.000 claims description 301
- 210000000130 stem cell Anatomy 0.000 claims description 169
- 239000000203 mixture Substances 0.000 claims description 95
- 238000000034 method Methods 0.000 claims description 78
- 238000002360 preparation method Methods 0.000 claims description 72
- 230000011164 ossification Effects 0.000 claims description 59
- 210000001808 exosome Anatomy 0.000 claims description 56
- 210000000988 bone and bone Anatomy 0.000 claims description 49
- 101150082840 SM30 gene Proteins 0.000 claims description 29
- 101100401000 Saccharomyces cerevisiae MEL2 gene Proteins 0.000 claims description 27
- 230000004069 differentiation Effects 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 26
- 239000006166 lysate Substances 0.000 claims description 26
- -1 HAND2 Proteins 0.000 claims description 22
- 239000000017 hydrogel Substances 0.000 claims description 21
- 108010035532 Collagen Proteins 0.000 claims description 20
- 102000008186 Collagen Human genes 0.000 claims description 20
- 229920001436 collagen Polymers 0.000 claims description 20
- 239000000515 collagen sponge Substances 0.000 claims description 20
- 210000001519 tissue Anatomy 0.000 claims description 20
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims description 18
- 108010028750 Integrin-Binding Sialoprotein Proteins 0.000 claims description 17
- 102000016921 Integrin-Binding Sialoprotein Human genes 0.000 claims description 17
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims description 16
- 108010010803 Gelatin Proteins 0.000 claims description 15
- 239000000969 carrier Substances 0.000 claims description 15
- 229920000159 gelatin Polymers 0.000 claims description 15
- 239000008273 gelatin Substances 0.000 claims description 15
- 235000019322 gelatine Nutrition 0.000 claims description 15
- 235000011852 gelatine desserts Nutrition 0.000 claims description 15
- 238000002054 transplantation Methods 0.000 claims description 15
- 101100398412 Arabidopsis thaliana ASK1 gene Proteins 0.000 claims description 14
- 239000000919 ceramic Substances 0.000 claims description 14
- 239000002131 composite material Substances 0.000 claims description 14
- 101000928535 Homo sapiens Protein delta homolog 1 Proteins 0.000 claims description 13
- 101001053754 Homo sapiens Type II iodothyronine deiodinase Proteins 0.000 claims description 13
- 102100036467 Protein delta homolog 1 Human genes 0.000 claims description 13
- 102100024060 Type II iodothyronine deiodinase Human genes 0.000 claims description 13
- 230000001737 promoting effect Effects 0.000 claims description 13
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 12
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 12
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 claims description 12
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims description 12
- 102100040557 Osteopontin Human genes 0.000 claims description 12
- 210000002744 extracellular matrix Anatomy 0.000 claims description 12
- 102100040995 Collagen alpha-1(XXI) chain Human genes 0.000 claims description 11
- 101000748976 Homo sapiens Collagen alpha-1(XXI) chain Proteins 0.000 claims description 11
- 101000976653 Homo sapiens Zinc finger protein ZIC 1 Proteins 0.000 claims description 11
- 102100023497 Zinc finger protein ZIC 1 Human genes 0.000 claims description 11
- 229920002674 hyaluronan Polymers 0.000 claims description 11
- 208000014674 injury Diseases 0.000 claims description 11
- 101000591210 Homo sapiens Receptor-type tyrosine-protein phosphatase-like N Proteins 0.000 claims description 10
- 101000825086 Homo sapiens Transcription factor SOX-11 Proteins 0.000 claims description 10
- 102100034091 Receptor-type tyrosine-protein phosphatase-like N Human genes 0.000 claims description 10
- 102100022415 Transcription factor SOX-11 Human genes 0.000 claims description 10
- 230000001225 therapeutic effect Effects 0.000 claims description 10
- 229920000954 Polyglycolide Polymers 0.000 claims description 9
- 210000002805 bone matrix Anatomy 0.000 claims description 9
- 230000022159 cartilage development Effects 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 9
- 239000004633 polyglycolic acid Substances 0.000 claims description 9
- 101000635895 Homo sapiens Myosin light chain 4 Proteins 0.000 claims description 8
- 101000976643 Homo sapiens Zinc finger protein ZIC 2 Proteins 0.000 claims description 8
- 102100030739 Myosin light chain 4 Human genes 0.000 claims description 8
- 102100023492 Zinc finger protein ZIC 2 Human genes 0.000 claims description 8
- 230000006378 damage Effects 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 229920001610 polycaprolactone Polymers 0.000 claims description 8
- 239000004632 polycaprolactone Substances 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 7
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 7
- 102100025683 Alkaline phosphatase, tissue-nonspecific isozyme Human genes 0.000 claims description 7
- 101000574445 Homo sapiens Alkaline phosphatase, tissue-nonspecific isozyme Proteins 0.000 claims description 7
- 108010044467 Isoenzymes Proteins 0.000 claims description 7
- 108010081689 Osteopontin Proteins 0.000 claims description 7
- 201000009859 Osteochondrosis Diseases 0.000 claims description 6
- 208000027418 Wounds and injury Diseases 0.000 claims description 6
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 6
- 230000000399 orthopedic effect Effects 0.000 claims description 6
- 108010073385 Fibrin Proteins 0.000 claims description 5
- 102000009123 Fibrin Human genes 0.000 claims description 5
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 5
- 210000002242 embryoid body Anatomy 0.000 claims description 5
- 229950003499 fibrin Drugs 0.000 claims description 5
- 210000005260 human cell Anatomy 0.000 claims description 5
- 229940099552 hyaluronan Drugs 0.000 claims description 5
- 230000008733 trauma Effects 0.000 claims description 5
- 102000016942 Elastin Human genes 0.000 claims description 4
- 108010014258 Elastin Proteins 0.000 claims description 4
- 206010060820 Joint injury Diseases 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 4
- 239000001506 calcium phosphate Substances 0.000 claims description 4
- 229920002549 elastin Polymers 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 4
- 108010082117 matrigel Proteins 0.000 claims description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 4
- 239000004626 polylactic acid Substances 0.000 claims description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 4
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 4
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 4
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 4
- 208000023178 Musculoskeletal disease Diseases 0.000 claims description 3
- 238000001727 in vivo Methods 0.000 claims description 3
- 230000002934 lysing effect Effects 0.000 claims description 3
- 208000032984 Intraoperative Complications Diseases 0.000 claims 2
- 102000004264 Osteopontin Human genes 0.000 claims 2
- 210000003127 knee Anatomy 0.000 claims 2
- 208000017445 musculoskeletal system disease Diseases 0.000 claims 2
- 230000002642 osteogeneic effect Effects 0.000 claims 1
- 230000002787 reinforcement Effects 0.000 claims 1
- 230000003014 reinforcing effect Effects 0.000 claims 1
- 230000002648 chondrogenic effect Effects 0.000 description 49
- 239000002609 medium Substances 0.000 description 31
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 30
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 30
- 239000003636 conditioned culture medium Substances 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 230000002188 osteogenic effect Effects 0.000 description 17
- 239000007943 implant Substances 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 230000000975 bioactive effect Effects 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 14
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 14
- 239000002953 phosphate buffered saline Substances 0.000 description 14
- 102100036601 Aggrecan core protein Human genes 0.000 description 13
- 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 13
- 239000003102 growth factor Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 108010057167 dimethylaniline monooxygenase (N-oxide forming) Proteins 0.000 description 12
- 239000002243 precursor Substances 0.000 description 12
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 11
- 101001023988 Homo sapiens Growth/differentiation factor 5 Proteins 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 10
- 238000004108 freeze drying Methods 0.000 description 9
- 239000003550 marker Substances 0.000 description 9
- 238000010899 nucleation Methods 0.000 description 9
- 102000017690 GABRB1 Human genes 0.000 description 8
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 8
- 101001001362 Homo sapiens Gamma-aminobutyric acid receptor subunit beta-1 Proteins 0.000 description 8
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- WBSMIPAMAXNXFS-UHFFFAOYSA-N 5-Nitro-2-(3-phenylpropylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCCC1=CC=CC=C1 WBSMIPAMAXNXFS-UHFFFAOYSA-N 0.000 description 7
- 108010067219 Aggrecans Proteins 0.000 description 7
- 102100040069 Aldehyde dehydrogenase 1A1 Human genes 0.000 description 7
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 7
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 7
- 102100028761 Heat shock 70 kDa protein 6 Human genes 0.000 description 7
- 102100025110 Homeobox protein Hox-A5 Human genes 0.000 description 7
- 101000890570 Homo sapiens Aldehyde dehydrogenase 1A1 Proteins 0.000 description 7
- 101001078680 Homo sapiens Heat shock 70 kDa protein 6 Proteins 0.000 description 7
- 101001077568 Homo sapiens Homeobox protein Hox-A5 Proteins 0.000 description 7
- 101000614436 Homo sapiens Keratin, type I cytoskeletal 14 Proteins 0.000 description 7
- 101000928278 Homo sapiens Natriuretic peptides B Proteins 0.000 description 7
- 101000613577 Homo sapiens Paired box protein Pax-2 Proteins 0.000 description 7
- 101000713585 Homo sapiens Tubulin beta-4A chain Proteins 0.000 description 7
- 102100040445 Keratin, type I cytoskeletal 14 Human genes 0.000 description 7
- 102100036836 Natriuretic peptides B Human genes 0.000 description 7
- 102100040852 Paired box protein Pax-2 Human genes 0.000 description 7
- 102100032251 Pro-thyrotropin-releasing hormone Human genes 0.000 description 7
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 7
- 102100036788 Tubulin beta-4A chain Human genes 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 230000006698 induction Effects 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- 102100031236 11-beta-hydroxysteroid dehydrogenase type 2 Human genes 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 102100039819 Actin, alpha cardiac muscle 1 Human genes 0.000 description 6
- 102100025215 CCN family member 5 Human genes 0.000 description 6
- 102100024153 Cadherin-15 Human genes 0.000 description 6
- 102100024316 Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Human genes 0.000 description 6
- 102100040499 Contactin-associated protein-like 2 Human genes 0.000 description 6
- 102100030091 Dickkopf-related protein 2 Human genes 0.000 description 6
- 102100032788 Dimethylaniline monooxygenase [N-oxide-forming] 1 Human genes 0.000 description 6
- 102100035041 Dimethylaniline monooxygenase [N-oxide-forming] 3 Human genes 0.000 description 6
- 102100038146 Homeobox protein goosecoid Human genes 0.000 description 6
- 101000845090 Homo sapiens 11-beta-hydroxysteroid dehydrogenase type 2 Proteins 0.000 description 6
- 101000959247 Homo sapiens Actin, alpha cardiac muscle 1 Proteins 0.000 description 6
- 101000934220 Homo sapiens CCN family member 5 Proteins 0.000 description 6
- 101000762242 Homo sapiens Cadherin-15 Proteins 0.000 description 6
- 101000714553 Homo sapiens Cadherin-3 Proteins 0.000 description 6
- 101001117044 Homo sapiens Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Proteins 0.000 description 6
- 101000749877 Homo sapiens Contactin-associated protein-like 2 Proteins 0.000 description 6
- 101000864647 Homo sapiens Dickkopf-related protein 2 Proteins 0.000 description 6
- 101001032602 Homo sapiens Homeobox protein goosecoid Proteins 0.000 description 6
- 101001007036 Homo sapiens Keratin, type I cuticular Ha4 Proteins 0.000 description 6
- 101000605006 Homo sapiens Lysosome-associated membrane glycoprotein 5 Proteins 0.000 description 6
- 101000958751 Homo sapiens Myosin-3 Proteins 0.000 description 6
- 101000831616 Homo sapiens Protachykinin-1 Proteins 0.000 description 6
- 101001123332 Homo sapiens Proteoglycan 4 Proteins 0.000 description 6
- 101000617796 Homo sapiens SPARC-related modular calcium-binding protein 1 Proteins 0.000 description 6
- 101000697510 Homo sapiens Stathmin-2 Proteins 0.000 description 6
- 102100028355 Keratin, type I cuticular Ha4 Human genes 0.000 description 6
- 102100038212 Lysosome-associated membrane glycoprotein 5 Human genes 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 102100038317 Myosin-3 Human genes 0.000 description 6
- 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 description 6
- 102100024304 Protachykinin-1 Human genes 0.000 description 6
- 102100028965 Proteoglycan 4 Human genes 0.000 description 6
- 102100021269 Regulator of G-protein signaling 1 Human genes 0.000 description 6
- 101710140408 Regulator of G-protein signaling 1 Proteins 0.000 description 6
- 108091006419 SLC25A12 Proteins 0.000 description 6
- 102100021995 SPARC-related modular calcium-binding protein 1 Human genes 0.000 description 6
- 102100028051 Stathmin-2 Human genes 0.000 description 6
- 229940112869 bone morphogenetic protein Drugs 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 108091005418 scavenger receptor class E Proteins 0.000 description 6
- 239000002356 single layer Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 5
- 102100038778 Amphiregulin Human genes 0.000 description 5
- 102000004888 Aquaporin 1 Human genes 0.000 description 5
- 108090001004 Aquaporin 1 Proteins 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 102100025221 CD70 antigen Human genes 0.000 description 5
- 108060001826 COP1 Proteins 0.000 description 5
- 102100025634 Caspase recruitment domain-containing protein 16 Human genes 0.000 description 5
- 102100028682 Claudin-11 Human genes 0.000 description 5
- 102100034622 Complement factor B Human genes 0.000 description 5
- 102100022874 Dexamethasone-induced Ras-related protein 1 Human genes 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 5
- 102100020921 Follistatin Human genes 0.000 description 5
- 102100020856 Forkhead box protein F1 Human genes 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 102100040895 Growth/differentiation factor 10 Human genes 0.000 description 5
- 102100037099 Homeobox protein MOX-1 Human genes 0.000 description 5
- 102100037102 Homeobox protein MOX-2 Human genes 0.000 description 5
- 102100028707 Homeobox protein MSX-1 Human genes 0.000 description 5
- 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 5
- 101000809450 Homo sapiens Amphiregulin Proteins 0.000 description 5
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 5
- 101000766989 Homo sapiens Claudin-11 Proteins 0.000 description 5
- 101000710032 Homo sapiens Complement factor B Proteins 0.000 description 5
- 101000620808 Homo sapiens Dexamethasone-induced Ras-related protein 1 Proteins 0.000 description 5
- 101000931668 Homo sapiens Follistatin Proteins 0.000 description 5
- 101000931494 Homo sapiens Forkhead box protein F1 Proteins 0.000 description 5
- 101000893563 Homo sapiens Growth/differentiation factor 10 Proteins 0.000 description 5
- 101000955035 Homo sapiens Homeobox protein MOX-1 Proteins 0.000 description 5
- 101000955037 Homo sapiens Homeobox protein MOX-2 Proteins 0.000 description 5
- 101000985653 Homo sapiens Homeobox protein MSX-1 Proteins 0.000 description 5
- 101000960337 Homo sapiens Intercellular adhesion molecule 5 Proteins 0.000 description 5
- 101000998027 Homo sapiens Keratin, type I cytoskeletal 17 Proteins 0.000 description 5
- 101001121082 Homo sapiens Mimecan Proteins 0.000 description 5
- 101000996111 Homo sapiens Neuroligin-4, X-linked Proteins 0.000 description 5
- 101000735484 Homo sapiens Paired box protein Pax-9 Proteins 0.000 description 5
- 101000701518 Homo sapiens Probable phospholipid-transporting ATPase IM Proteins 0.000 description 5
- 101001099423 Homo sapiens Proenkephalin-A Proteins 0.000 description 5
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 description 5
- 101000903887 Homo sapiens Protein BEX1 Proteins 0.000 description 5
- 101000651309 Homo sapiens Retinoic acid receptor responder protein 1 Proteins 0.000 description 5
- 101000708790 Homo sapiens SPARC-related modular calcium-binding protein 2 Proteins 0.000 description 5
- 101000663381 Homo sapiens Scavenger receptor cysteine-rich domain-containing group B protein Proteins 0.000 description 5
- 102100039919 Intercellular adhesion molecule 5 Human genes 0.000 description 5
- 102100033511 Keratin, type I cytoskeletal 17 Human genes 0.000 description 5
- 102100026632 Mimecan Human genes 0.000 description 5
- 102100034441 Neuroligin-4, X-linked Human genes 0.000 description 5
- 102100034901 Paired box protein Pax-9 Human genes 0.000 description 5
- 102100030468 Probable phospholipid-transporting ATPase IM Human genes 0.000 description 5
- 102100038931 Proenkephalin-A Human genes 0.000 description 5
- 102100040120 Prominin-1 Human genes 0.000 description 5
- 102100024042 Protein BEX1 Human genes 0.000 description 5
- 102000043322 Reelin Human genes 0.000 description 5
- 108700038365 Reelin Proteins 0.000 description 5
- 101150057388 Reln gene Proteins 0.000 description 5
- 102100027682 Retinoic acid receptor responder protein 1 Human genes 0.000 description 5
- 102100032724 SPARC-related modular calcium-binding protein 2 Human genes 0.000 description 5
- 102100038959 Scavenger receptor cysteine-rich domain-containing group B protein Human genes 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 5
- 210000000845 cartilage Anatomy 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 101710137984 4-O-beta-D-mannosyl-D-glucose phosphorylase Proteins 0.000 description 4
- 102100026446 Aldo-keto reductase family 1 member C1 Human genes 0.000 description 4
- 102100040743 Alpha-crystallin B chain Human genes 0.000 description 4
- 102100024075 Alpha-internexin Human genes 0.000 description 4
- 102100036824 Annexin A8 Human genes 0.000 description 4
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 4
- 102100023074 Calcium-activated potassium channel subunit beta-1 Human genes 0.000 description 4
- 102100030006 Calpain-5 Human genes 0.000 description 4
- 102100025278 Coxsackievirus and adenovirus receptor Human genes 0.000 description 4
- 102100039439 DNA-binding protein inhibitor ID-4 Human genes 0.000 description 4
- 102100036411 Dermatopontin Human genes 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 4
- 102100020848 Forkhead box protein F2 Human genes 0.000 description 4
- 102100037156 Gap junction beta-2 protein Human genes 0.000 description 4
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 4
- 101150017737 HSPB3 gene Proteins 0.000 description 4
- 102100039168 Heat shock protein beta-3 Human genes 0.000 description 4
- 102100040615 Homeobox protein MSX-2 Human genes 0.000 description 4
- 101000718028 Homo sapiens Aldo-keto reductase family 1 member C1 Proteins 0.000 description 4
- 101000891982 Homo sapiens Alpha-crystallin B chain Proteins 0.000 description 4
- 101000833549 Homo sapiens Alpha-internexin Proteins 0.000 description 4
- 101000928300 Homo sapiens Annexin A8 Proteins 0.000 description 4
- 101001049849 Homo sapiens Calcium-activated potassium channel subunit beta-1 Proteins 0.000 description 4
- 101000793666 Homo sapiens Calpain-5 Proteins 0.000 description 4
- 101000858031 Homo sapiens Coxsackievirus and adenovirus receptor Proteins 0.000 description 4
- 101001036276 Homo sapiens DNA-binding protein inhibitor ID-4 Proteins 0.000 description 4
- 101000929047 Homo sapiens Dermatopontin Proteins 0.000 description 4
- 101000931482 Homo sapiens Forkhead box protein F2 Proteins 0.000 description 4
- 101000954092 Homo sapiens Gap junction beta-2 protein Proteins 0.000 description 4
- 101000967222 Homo sapiens Homeobox protein MSX-2 Proteins 0.000 description 4
- 101001076312 Homo sapiens Insulin growth factor-like family member 3 Proteins 0.000 description 4
- 101000840275 Homo sapiens Interferon alpha-inducible protein 27, mitochondrial Proteins 0.000 description 4
- 101001128393 Homo sapiens Interferon-induced GTP-binding protein Mx1 Proteins 0.000 description 4
- 101001076418 Homo sapiens Interleukin-1 receptor type 1 Proteins 0.000 description 4
- 101001055956 Homo sapiens Mannan-binding lectin serine protease 1 Proteins 0.000 description 4
- 101000584362 Homo sapiens Myosin-binding protein H Proteins 0.000 description 4
- 101000979249 Homo sapiens Neuromodulin Proteins 0.000 description 4
- 101001069727 Homo sapiens Paired mesoderm homeobox protein 1 Proteins 0.000 description 4
- 101000595669 Homo sapiens Pituitary homeobox 2 Proteins 0.000 description 4
- 101000684673 Homo sapiens Protein APCDD1 Proteins 0.000 description 4
- 101001019136 Homo sapiens Putative methyltransferase-like protein 7A Proteins 0.000 description 4
- 101000864786 Homo sapiens Secreted frizzled-related protein 2 Proteins 0.000 description 4
- 101000998897 Homo sapiens Serine protease HTRA3 Proteins 0.000 description 4
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 4
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 4
- 101000764260 Homo sapiens Troponin T, cardiac muscle Proteins 0.000 description 4
- 102100025962 Insulin growth factor-like family member 3 Human genes 0.000 description 4
- 102100029604 Interferon alpha-inducible protein 27, mitochondrial Human genes 0.000 description 4
- 102100031802 Interferon-induced GTP-binding protein Mx1 Human genes 0.000 description 4
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 description 4
- 102100026061 Mannan-binding lectin serine protease 1 Human genes 0.000 description 4
- 102100039809 Matrix Gla protein Human genes 0.000 description 4
- 101710147263 Matrix Gla protein Proteins 0.000 description 4
- 102100030626 Myosin-binding protein H Human genes 0.000 description 4
- 102100023206 Neuromodulin Human genes 0.000 description 4
- 102100033786 Paired mesoderm homeobox protein 1 Human genes 0.000 description 4
- 102100036090 Pituitary homeobox 2 Human genes 0.000 description 4
- 102100039277 Pleiotrophin Human genes 0.000 description 4
- 102100023735 Protein APCDD1 Human genes 0.000 description 4
- 102100034758 Putative methyltransferase-like protein 7A Human genes 0.000 description 4
- 102000007460 S100 Calcium-Binding Protein A4 Human genes 0.000 description 4
- 108010085149 S100 Calcium-Binding Protein A4 Proteins 0.000 description 4
- 102100030054 Secreted frizzled-related protein 2 Human genes 0.000 description 4
- 102100038081 Signal transducer CD24 Human genes 0.000 description 4
- 108010057722 Synaptosomal-Associated Protein 25 Proteins 0.000 description 4
- 102000004183 Synaptosomal-Associated Protein 25 Human genes 0.000 description 4
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 4
- 102100026893 Troponin T, cardiac muscle Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 102100029819 UDP-glucuronosyltransferase 2B7 Human genes 0.000 description 4
- 101710200333 UDP-glucuronosyltransferase 2B7 Proteins 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000013592 cell lysate Substances 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 4
- 229960003957 dexamethasone Drugs 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000007918 intramuscular administration Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 102100022586 17-beta-hydroxysteroid dehydrogenase type 2 Human genes 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 3
- 102100029756 Cadherin-6 Human genes 0.000 description 3
- 102100027473 Cartilage oligomeric matrix protein Human genes 0.000 description 3
- 101710176668 Cartilage oligomeric matrix protein Proteins 0.000 description 3
- 102100031047 Coiled-coil domain-containing protein 3 Human genes 0.000 description 3
- 102100022640 Collagen alpha-1(XV) chain Human genes 0.000 description 3
- 102100032756 Cysteine-rich protein 1 Human genes 0.000 description 3
- 102100038493 Cytokine receptor-like factor 1 Human genes 0.000 description 3
- 102100033582 Dermokine Human genes 0.000 description 3
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 102100032066 EMI domain-containing protein 1 Human genes 0.000 description 3
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 3
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 3
- 101001045223 Homo sapiens 17-beta-hydroxysteroid dehydrogenase type 2 Proteins 0.000 description 3
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 3
- 101000945426 Homo sapiens CB1 cannabinoid receptor-interacting protein 1 Proteins 0.000 description 3
- 101000794604 Homo sapiens Cadherin-6 Proteins 0.000 description 3
- 101000777372 Homo sapiens Coiled-coil domain-containing protein 3 Proteins 0.000 description 3
- 101000899935 Homo sapiens Collagen alpha-1(XV) chain Proteins 0.000 description 3
- 101000942084 Homo sapiens Cysteine-rich protein 1 Proteins 0.000 description 3
- 101000956431 Homo sapiens Cytokine receptor-like factor 1 Proteins 0.000 description 3
- 101000872044 Homo sapiens Dermokine Proteins 0.000 description 3
- 101000921258 Homo sapiens EMI domain-containing protein 1 Proteins 0.000 description 3
- 101000610630 Homo sapiens Inactive serine protease 35 Proteins 0.000 description 3
- 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 3
- 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 description 3
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 3
- 101001000104 Homo sapiens Myosin-11 Proteins 0.000 description 3
- 101000634538 Homo sapiens Neuronal PAS domain-containing protein 1 Proteins 0.000 description 3
- 101001069723 Homo sapiens Paired mesoderm homeobox protein 2 Proteins 0.000 description 3
- 101001095308 Homo sapiens Periostin Proteins 0.000 description 3
- 101001121506 Homo sapiens Protein odd-skipped-related 2 Proteins 0.000 description 3
- 101000825960 Homo sapiens R-spondin-3 Proteins 0.000 description 3
- 101000766253 Homo sapiens TLR4 interactor with leucine rich repeats Proteins 0.000 description 3
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 description 3
- 101000835083 Homo sapiens Tissue factor pathway inhibitor 2 Proteins 0.000 description 3
- 101000652720 Homo sapiens Transgelin-3 Proteins 0.000 description 3
- 101000598051 Homo sapiens Transmembrane protein 119 Proteins 0.000 description 3
- 102100040339 Inactive serine protease 35 Human genes 0.000 description 3
- 102100025947 Insulin-like growth factor II Human genes 0.000 description 3
- 102100033501 Interleukin-32 Human genes 0.000 description 3
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 102100036639 Myosin-11 Human genes 0.000 description 3
- 102100029052 Neuronal PAS domain-containing protein 1 Human genes 0.000 description 3
- 102100033829 Paired mesoderm homeobox protein 2 Human genes 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 102100037765 Periostin Human genes 0.000 description 3
- 102100025660 Protein odd-skipped-related 2 Human genes 0.000 description 3
- 102100022766 R-spondin-3 Human genes 0.000 description 3
- 102100026308 TLR4 interactor with leucine rich repeats Human genes 0.000 description 3
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 description 3
- 102100026134 Tissue factor pathway inhibitor 2 Human genes 0.000 description 3
- 102100030986 Transgelin-3 Human genes 0.000 description 3
- 102100037029 Transmembrane protein 119 Human genes 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 108010031318 Vitronectin Proteins 0.000 description 3
- 102100035140 Vitronectin Human genes 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 210000001163 endosome Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229960002429 proline Drugs 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 2
- YMZPQKXPKZZSFV-CPWYAANMSA-N 2-[3-[(1r)-1-[(2s)-1-[(2s)-2-[(1r)-cyclohex-2-en-1-yl]-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carbonyl]oxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC[C@H](C=1C=C(OCC(O)=O)C=CC=1)OC(=O)[C@H]1N(C(=O)[C@@H]([C@H]2C=CCCC2)C=2C=C(OC)C(OC)=C(OC)C=2)CCCC1 YMZPQKXPKZZSFV-CPWYAANMSA-N 0.000 description 2
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 102000000503 Collagen Type II Human genes 0.000 description 2
- 108010041390 Collagen Type II Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102100023227 E3 SUMO-protein ligase EGR2 Human genes 0.000 description 2
- 102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 2
- 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 description 2
- 101001049692 Homo sapiens E3 SUMO-protein ligase EGR2 Proteins 0.000 description 2
- 101000836222 Homo sapiens Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 2
- 101000840566 Homo sapiens Insulin-like growth factor-binding protein 5 Proteins 0.000 description 2
- 101001082060 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 3 Proteins 0.000 description 2
- 101001023271 Homo sapiens Laminin subunit gamma-2 Proteins 0.000 description 2
- 101000947695 Homo sapiens Microfibrillar-associated protein 5 Proteins 0.000 description 2
- 101000595182 Homo sapiens Podocan Proteins 0.000 description 2
- 101000611663 Homo sapiens Prolargin Proteins 0.000 description 2
- 101000756808 Homo sapiens Repulsive guidance molecule A Proteins 0.000 description 2
- 101000626386 Homo sapiens Synaptotagmin-12 Proteins 0.000 description 2
- 101000655125 Homo sapiens Transmembrane protein 100 Proteins 0.000 description 2
- 102100029225 Insulin-like growth factor-binding protein 5 Human genes 0.000 description 2
- 102100027302 Interferon-induced protein with tetratricopeptide repeats 3 Human genes 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182821 L-proline Natural products 0.000 description 2
- 102100035159 Laminin subunit gamma-2 Human genes 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 102100036203 Microfibrillar-associated protein 5 Human genes 0.000 description 2
- 102100036036 Podocan Human genes 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102100040659 Prolargin Human genes 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 102100022813 Repulsive guidance molecule A Human genes 0.000 description 2
- 102100024619 Synaptotagmin-12 Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 102100033028 Transmembrane protein 100 Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 108010076089 accutase Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000000512 collagen gel Substances 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 230000001582 osteoblastic effect Effects 0.000 description 2
- 210000005009 osteogenic cell Anatomy 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 210000003660 reticulum Anatomy 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 210000002536 stromal cell Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- IDOQDZANRZQBTP-UHFFFAOYSA-N 2-[2-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=CC=C1OCCO IDOQDZANRZQBTP-UHFFFAOYSA-N 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
- 102100022464 5'-nucleotidase Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108010087765 Antipain Proteins 0.000 description 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
- 102100025222 CD63 antigen Human genes 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102100036217 Collagen alpha-1(X) chain Human genes 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 description 1
- 102100032248 Dysferlin Human genes 0.000 description 1
- 102100037241 Endoglin Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 206010049811 Extraskeletal ossification Diseases 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 108010090254 Growth Differentiation Factor 5 Proteins 0.000 description 1
- 101710204282 Growth/differentiation factor 5 Proteins 0.000 description 1
- 102000006354 HLA-DR Antigens Human genes 0.000 description 1
- 108010058597 HLA-DR Antigens Proteins 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 208000034970 Heterotopic Ossification Diseases 0.000 description 1
- 102100022373 Homeobox protein DLX-5 Human genes 0.000 description 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
- 101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 1
- 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 1
- 101000875027 Homo sapiens Collagen alpha-1(X) chain Proteins 0.000 description 1
- 101001016184 Homo sapiens Dysferlin Proteins 0.000 description 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000901627 Homo sapiens Homeobox protein DLX-5 Proteins 0.000 description 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000835984 Homo sapiens SLIT and NTRK-like protein 6 Proteins 0.000 description 1
- 101000597862 Homo sapiens Transmembrane protein 199 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100022338 Integrin alpha-M Human genes 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 239000012083 RIPA buffer Substances 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102100025504 SLIT and NTRK-like protein 6 Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 229920013808 TRITON DF-16 Polymers 0.000 description 1
- 206010043248 Tendon rupture Diseases 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 102100030951 Tissue factor pathway inhibitor Human genes 0.000 description 1
- 102100035335 Transmembrane protein 199 Human genes 0.000 description 1
- 229920004929 Triton X-114 Polymers 0.000 description 1
- 229920004896 Triton X-405 Polymers 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 101100286583 Xenopus laevis igf3 gene Proteins 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
- 208000037873 arthrodesis Diseases 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 238000009583 bone marrow aspiration Methods 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 229940087828 buprenex Drugs 0.000 description 1
- UAIXRPCCYXNJMQ-RZIPZOSSSA-N buprenorphine hydrochlorie Chemical compound [Cl-].C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)C[NH+]2CC1CC1 UAIXRPCCYXNJMQ-RZIPZOSSSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000009816 chondrogenic differentiation Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000035194 endochondral ossification Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 210000003559 hypertrophic chondrocyte Anatomy 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002843 lactate dehydrogenase assay Methods 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000004819 osteoinduction Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000002135 phase contrast microscopy Methods 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 108010023714 recombinant human bone morphogenetic protein-2 Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000000513 rotator cuff Anatomy 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- QYHFIVBSNOWOCQ-UHFFFAOYSA-N selenic acid Chemical compound O[Se](O)(=O)=O QYHFIVBSNOWOCQ-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/80—Hyaluronan
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562172808P | 2015-06-09 | 2015-06-09 | |
| US62/172,808 | 2015-06-09 | ||
| PCT/US2016/036778 WO2016201154A1 (en) | 2015-06-09 | 2016-06-09 | Osteogenic graft forming unit |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018520750A JP2018520750A (ja) | 2018-08-02 |
| JP2018520750A5 JP2018520750A5 (enExample) | 2019-07-11 |
| JP6875297B2 true JP6875297B2 (ja) | 2021-05-19 |
Family
ID=57504258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017564535A Expired - Fee Related JP6875297B2 (ja) | 2015-06-09 | 2016-06-09 | 骨形成性移植片形成ユニット |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20180325958A1 (enExample) |
| EP (1) | EP3307287A4 (enExample) |
| JP (1) | JP6875297B2 (enExample) |
| AU (1) | AU2016274785A1 (enExample) |
| CA (1) | CA2988778A1 (enExample) |
| HK (1) | HK1254314A1 (enExample) |
| WO (1) | WO2016201154A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
| WO2018115871A1 (en) * | 2016-12-20 | 2018-06-28 | The University Of Birmingham | Composition and method for bone production |
| JP7204730B2 (ja) * | 2017-03-31 | 2023-01-16 | セラム バイオメディカル， インコーポレイテッド | 生体適合性馴化細胞培地組成物およびその使用 |
| CN108452378B (zh) * | 2018-02-08 | 2020-10-23 | 中山大学附属第一医院 | 一种3d生物打印成型方法 |
| CN108310463B (zh) * | 2018-02-08 | 2020-10-23 | 中山大学附属第一医院 | 一种3d打印生物墨水及其制备方法 |
| KR102232283B1 (ko) * | 2018-07-26 | 2021-03-25 | 에이비온 주식회사 | 연골세포 분화 마커 |
| CN109568665B (zh) * | 2018-12-28 | 2021-12-10 | 中国医科大学附属第一医院 | 负载脂肪干细胞外泌体的温敏型可注射水凝胶及其制备方法和应用 |
| CA3137836C (en) * | 2019-04-23 | 2024-04-09 | Cellatoz Therapeutics, Inc. | Method for regulation of selective differentiation of musculoskeletal stem cells |
| KR102236635B1 (ko) * | 2019-09-04 | 2021-04-13 | 경북대학교 산학협력단 | Meox2 억제제를 유효성분으로 포함하는 발치와 골 재생 촉진용 조성물 |
| KR102104933B1 (ko) * | 2019-10-31 | 2020-04-27 | 주식회사 라이프온 | 줄기세포 유래 엑소좀을 함유하는 치아 재강화 또는 치아골 이식재 조성물 및 그 제조방법 |
| CN110684710A (zh) * | 2019-11-23 | 2020-01-14 | 吉林省蔚来生物科技有限公司 | 一种骨膜生物支架与异体种子细胞复合的培养方法 |
| JP2021159499A (ja) * | 2020-04-01 | 2021-10-11 | 株式会社Dr.Cherry | 骨形成を促進することに用いられる新生骨の支持体 |
| KR102463245B1 (ko) * | 2020-06-19 | 2022-11-07 | 동국대학교 산학협력단 | Mettl7a 과발현 줄기세포를 포함하는 골재생용 조성물, 이를 제조하는 방법 및 이를 포함하는 세포치료제 |
| CN113249332A (zh) * | 2021-07-15 | 2021-08-13 | 北京大学第三医院（北京大学第三临床医学院） | 一种alpl基因缺失骨髓间充质干细胞的建立方法 |
| EP4230232A1 (en) | 2022-02-16 | 2023-08-23 | Hacettepe Üniversitesi | Binding of calcium phosphate bioceramic and exosomes via annexin v mediator molecule |
| CN115957378B (zh) * | 2023-02-08 | 2024-10-22 | 上海交通大学医学院附属瑞金医院 | 一种骨修复组合物及其制备方法和应用 |
| CN118028212B (zh) * | 2024-04-12 | 2024-06-18 | 广东医科大学附属医院 | 土元外泌体在制备抗骨质疏松药物中的应用、药物 |
| CN120209114A (zh) * | 2025-03-07 | 2025-06-27 | 首都医科大学 | 一种含有penk蛋白的组合物及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1722765A2 (en) * | 2004-01-28 | 2006-11-22 | The Regents of The University of Michigan | Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| CH700138B1 (it) * | 2008-12-19 | 2012-12-14 | Ind Biomediche Insubri S A | Matrice per impianto osseo e procedimento di preparazione della stessa. |
| WO2013010045A1 (en) * | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
| CN104487569A (zh) * | 2012-05-10 | 2015-04-01 | 生物材料细胞公司 | 间充质干细胞的成骨分化 |
| US20140178988A1 (en) * | 2012-10-08 | 2014-06-26 | Biotime, Inc. | Differentiated Progeny of Clonal Progenitor Cell Lines |
| AU2014284440B2 (en) * | 2013-07-01 | 2018-07-19 | Amit Prakash Govil | Soft tissue implant |
| CA2923002C (en) * | 2013-09-02 | 2022-12-13 | Muffin Incorporated | Products comprising an extracellular matrix tissue material and osteogenic protein |
-
2016
- 2016-06-09 EP EP16808325.1A patent/EP3307287A4/en not_active Withdrawn
- 2016-06-09 CA CA2988778A patent/CA2988778A1/en not_active Abandoned
- 2016-06-09 HK HK18113282.0A patent/HK1254314A1/zh unknown
- 2016-06-09 JP JP2017564535A patent/JP6875297B2/ja not_active Expired - Fee Related
- 2016-06-09 WO PCT/US2016/036778 patent/WO2016201154A1/en not_active Ceased
- 2016-06-09 AU AU2016274785A patent/AU2016274785A1/en not_active Abandoned
-
2017
- 2017-12-07 US US15/834,242 patent/US20180325958A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016274785A1 (en) | 2017-12-07 |
| CA2988778A1 (en) | 2016-12-15 |
| EP3307287A1 (en) | 2018-04-18 |
| EP3307287A4 (en) | 2018-12-19 |
| JP2018520750A (ja) | 2018-08-02 |
| US20180325958A1 (en) | 2018-11-15 |
| HK1254314A1 (zh) | 2019-07-19 |
| WO2016201154A1 (en) | 2016-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6875297B2 (ja) | 骨形成性移植片形成ユニット | |
| US11357889B2 (en) | Native soft tissue matrix for therapeutic applications | |
| Liu et al. | Robust bone regeneration through endochondral ossification of human mesenchymal stem cells within their own extracellular matrix | |
| Nöth et al. | Cell delivery therapeutics for musculoskeletal regeneration | |
| US5919702A (en) | Production of cartilage tissue using cells isolated from Wharton's jelly | |
| JP5483035B2 (ja) | 動物組織の粉末を利用した多孔性３次元支持体の製造方法およびこれを利用して製造された多孔性３次元支持体 | |
| Nukavarapu et al. | Regenerative engineering of musculoskeletal tissues and interfaces | |
| Ivkovic et al. | Regenerative medicine and tissue engineering in orthopaedic surgery | |
| KR100920951B1 (ko) | 미분화 인간 지방조직 유래 줄기세포를 포함하는 골 재생용복합 지지체 | |
| CN111107887B (zh) | 包含脂肪干细胞的生物材料及其制备方法 | |
| US20160067377A1 (en) | Stem Cell Seeded Natural Substrates and Methods Relating Thereto | |
| Nie et al. | Engineering a multiphasic, integrated graft with a biologically developed cartilage–bone interface for osteochondral defect repair | |
| CN112203702A (zh) | 富含脱细胞化骨细胞外基质水凝胶的脱细胞化骨生物材料 | |
| KR101851019B1 (ko) | 양성 연골종양세포를 이용하여 제조한 연골기질 및 이의 제조방법 | |
| JP2003235953A (ja) | フォスフォフォリンを含む複合生体材料 | |
| CN111094551A (zh) | 包含脂肪干细胞的生物材料及其制备方法 | |
| Ohno et al. | Effect of type I and type II collagen sponges as 3D scaffolds for hyaline cartilage-like tissue regeneration on phenotypic control of seeded chondrocytes in vitro | |
| US20190201451A1 (en) | Allografts containing viable cells and methods therof | |
| FR2883187A1 (fr) | Materiau de reparation de l'os utilisant un chondrocyte ayant le potentiel pour l'hypertrophie et un substitut osseux | |
| KR20110032433A (ko) | 세포이식술을 위한 혼합세포복합체인 세포스페로이드의 제조방법 및 이의 이용방법 | |
| WO2022214693A1 (en) | Marine scaffolds for human tissue generation | |
| KR101539822B1 (ko) | 줄기세포의 3차원 배양을 통한 고농축 배양액의 제조방법 및 고농축 배양액의 용도 | |
| Hanetseder | Secretome products derived from human induced pluripotent stem cells for cell-free bone tissue engineering | |
| WO2025154802A1 (ja) | 骨補填材、及びその製造方法 | |
| WO2024192329A1 (en) | Methods for producing stable human chondroctyes and their use for promoting cartillage growth and repair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20180727 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20180727 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190607 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190607 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200728 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201023 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210323 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210422 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6875297 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |